 | • レポートコード：MRC2-11QY12068 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は痛風疾患治療のグローバル市場について調査・分析したレポートです。種類別（急性痛風、慢性痛風）市場規模、用途別（病院、クリニック、在宅医療、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別痛風疾患治療の競争状況、市場シェア ・世界の痛風疾患治療市場：種類別市場規模 2015年-2020年（急性痛風、慢性痛風） ・世界の痛風疾患治療市場：種類別市場規模予測 2021年-2026年（急性痛風、慢性痛風） ・世界の痛風疾患治療市場：用途別市場規模 2015年-2020年（病院、クリニック、在宅医療、その他） ・世界の痛風疾患治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、在宅医療、その他） ・北米の痛風疾患治療市場分析：米国、カナダ ・ヨーロッパの痛風疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの痛風疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の痛風疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの痛風疾患治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda Pharmaceutical、Novartis、Savient Pharmaceuticals、AstraZeneca、GlaxoSmithKline、Merck& Co、Teijin Pharma、Regeneron Pharmaceuticals、Polaris、BioCryst Pharmaceuticals、Nippon Chemiphar、JW Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis.
The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and introduction of niche drugs are other factors boosting the growth of the global gout disease treatment market.
Market Analysis and Insights: Global Gout Disease Treatment Market
The global Gout Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gout Disease Treatment Scope and Market Size
Gout Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gout Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda Pharmaceutical
Novartis
Savient Pharmaceuticals
AstraZeneca
GlaxoSmithKline
Merck& Co
Teijin Pharma
Regeneron Pharmaceuticals
Polaris
BioCryst Pharmaceuticals
Nippon Chemiphar
JW Pharmaceutical
Market segment by Type, the product can be split into
Acute Gout
Chronic Gout
Market segment by Application, split into
Hospitals
Clinics
Homecare Settings
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gout Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Gout Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acute Gout
1.4.3 Chronic Gout
1.5 Market by Application
1.5.1 Global Gout Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Homecare Settings
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gout Disease Treatment Market Perspective (2015-2026)
2.2 Global Gout Disease Treatment Growth Trends by Regions
2.2.1 Gout Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gout Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Gout Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gout Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Gout Disease Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gout Disease Treatment Players by Market Size
3.1.1 Global Top Gout Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Gout Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Gout Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gout Disease Treatment Market Concentration Ratio
3.2.1 Global Gout Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gout Disease Treatment Revenue in 2019
3.3 Gout Disease Treatment Key Players Head office and Area Served
3.4 Key Players Gout Disease Treatment Product Solution and Service
3.5 Date of Enter into Gout Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gout Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Gout Disease Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gout Disease Treatment Market Size by Application (2015-2020)
5.2 Global Gout Disease Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gout Disease Treatment Market Size (2015-2020)
6.2 Gout Disease Treatment Key Players in North America (2019-2020)
6.3 North America Gout Disease Treatment Market Size by Type (2015-2020)
6.4 North America Gout Disease Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gout Disease Treatment Market Size (2015-2020)
7.2 Gout Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Gout Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Gout Disease Treatment Market Size by Application (2015-2020)
8 China
8.1 China Gout Disease Treatment Market Size (2015-2020)
8.2 Gout Disease Treatment Key Players in China (2019-2020)
8.3 China Gout Disease Treatment Market Size by Type (2015-2020)
8.4 China Gout Disease Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gout Disease Treatment Market Size (2015-2020)
9.2 Gout Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Gout Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Gout Disease Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gout Disease Treatment Market Size (2015-2020)
10.2 Gout Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gout Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Gout Disease Treatment Market Size by Application (2015-2020)
11 India
11.1 India Gout Disease Treatment Market Size (2015-2020)
11.2 Gout Disease Treatment Key Players in India (2019-2020)
11.3 India Gout Disease Treatment Market Size by Type (2015-2020)
11.4 India Gout Disease Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gout Disease Treatment Market Size (2015-2020)
12.2 Gout Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Gout Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Gout Disease Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Details
13.1.2 Takeda Pharmaceutical Business Overview
13.1.3 Takeda Pharmaceutical Gout Disease Treatment Introduction
13.1.4 Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2015-2020))
13.1.5 Takeda Pharmaceutical Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Gout Disease Treatment Introduction
13.2.4 Novartis Revenue in Gout Disease Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Savient Pharmaceuticals
13.3.1 Savient Pharmaceuticals Company Details
13.3.2 Savient Pharmaceuticals Business Overview
13.3.3 Savient Pharmaceuticals Gout Disease Treatment Introduction
13.3.4 Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020)
13.3.5 Savient Pharmaceuticals Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Gout Disease Treatment Introduction
13.4.4 AstraZeneca Revenue in Gout Disease Treatment Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Gout Disease Treatment Introduction
13.5.4 GlaxoSmithKline Revenue in Gout Disease Treatment Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Merck& Co
13.6.1 Merck& Co Company Details
13.6.2 Merck& Co Business Overview
13.6.3 Merck& Co Gout Disease Treatment Introduction
13.6.4 Merck& Co Revenue in Gout Disease Treatment Business (2015-2020)
13.6.5 Merck& Co Recent Development
13.7 Teijin Pharma
13.7.1 Teijin Pharma Company Details
13.7.2 Teijin Pharma Business Overview
13.7.3 Teijin Pharma Gout Disease Treatment Introduction
13.7.4 Teijin Pharma Revenue in Gout Disease Treatment Business (2015-2020)
13.7.5 Teijin Pharma Recent Development
13.8 Regeneron Pharmaceuticals
13.8.1 Regeneron Pharmaceuticals Company Details
13.8.2 Regeneron Pharmaceuticals Business Overview
13.8.3 Regeneron Pharmaceuticals Gout Disease Treatment Introduction
13.8.4 Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020)
13.8.5 Regeneron Pharmaceuticals Recent Development
13.9 Polaris
13.9.1 Polaris Company Details
13.9.2 Polaris Business Overview
13.9.3 Polaris Gout Disease Treatment Introduction
13.9.4 Polaris Revenue in Gout Disease Treatment Business (2015-2020)
13.9.5 Polaris Recent Development
13.10 BioCryst Pharmaceuticals
13.10.1 BioCryst Pharmaceuticals Company Details
13.10.2 BioCryst Pharmaceuticals Business Overview
13.10.3 BioCryst Pharmaceuticals Gout Disease Treatment Introduction
13.10.4 BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020)
13.10.5 BioCryst Pharmaceuticals Recent Development
13.11 Nippon Chemiphar
10.11.1 Nippon Chemiphar Company Details
10.11.2 Nippon Chemiphar Business Overview
10.11.3 Nippon Chemiphar Gout Disease Treatment Introduction
10.11.4 Nippon Chemiphar Revenue in Gout Disease Treatment Business (2015-2020)
10.11.5 Nippon Chemiphar Recent Development
13.12 JW Pharmaceutical
10.12.1 JW Pharmaceutical Company Details
10.12.2 JW Pharmaceutical Business Overview
10.12.3 JW Pharmaceutical Gout Disease Treatment Introduction
10.12.4 JW Pharmaceutical Revenue in Gout Disease Treatment Business (2015-2020)
10.12.5 JW Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gout Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Gout Disease Treatment Revenue
Table 3. Ranking of Global Top Gout Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gout Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acute Gout
Table 6. Key Players of Chronic Gout
Table 7. Global Gout Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Gout Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Gout Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Gout Disease Treatment Market Share by Regions (2015-2020)
Table 11. Global Gout Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Gout Disease Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Gout Disease Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Gout Disease Treatment Players
Table 18. Global Gout Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Gout Disease Treatment Market Share by Players (2015-2020)
Table 20. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Disease Treatment as of 2019)
Table 21. Global Gout Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gout Disease Treatment Product Solution and Service
Table 24. Date of Enter into Gout Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Gout Disease Treatment Market Size Share by Type (2015-2020)
Table 28. Global Gout Disease Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Gout Disease Treatment Market Size Share by Application (2015-2020)
Table 30. Global Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Gout Disease Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Gout Disease Treatment Market Share (2019-2020)
Table 34. North America Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Gout Disease Treatment Market Share by Type (2015-2020)
Table 36. North America Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Gout Disease Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Gout Disease Treatment Market Share (2019-2020)
Table 40. Europe Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Gout Disease Treatment Market Share by Type (2015-2020)
Table 42. Europe Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Gout Disease Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Gout Disease Treatment Market Share (2019-2020)
Table 46. China Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Gout Disease Treatment Market Share by Type (2015-2020)
Table 48. China Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Gout Disease Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Gout Disease Treatment Market Share (2019-2020)
Table 52. Japan Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Gout Disease Treatment Market Share by Type (2015-2020)
Table 54. Japan Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Gout Disease Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Gout Disease Treatment Market Share (2019-2020)
Table 58. Southeast Asia Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Gout Disease Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Gout Disease Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Gout Disease Treatment Market Share (2019-2020)
Table 64. India Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Gout Disease Treatment Market Share by Type (2015-2020)
Table 66. India Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Gout Disease Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Gout Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Gout Disease Treatment Market Share (2019-2020)
Table 70. Central & South America Gout Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Gout Disease Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Gout Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Gout Disease Treatment Market Share by Application (2015-2020)
Table 74. Takeda Pharmaceutical Company Details
Table 75. Takeda Pharmaceutical Business Overview
Table 76. Takeda Pharmaceutical Product
Table 77. Takeda Pharmaceutical Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 78. Takeda Pharmaceutical Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Novartis Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 83. Novartis Recent Development
Table 84. Savient Pharmaceuticals Company Details
Table 85. Savient Pharmaceuticals Business Overview
Table 86. Savient Pharmaceuticals Product
Table 87. Savient Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 88. Savient Pharmaceuticals Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Product
Table 92. AstraZeneca Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 93. AstraZeneca Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 98. GlaxoSmithKline Recent Development
Table 99. Merck& Co Company Details
Table 100. Merck& Co Business Overview
Table 101. Merck& Co Product
Table 102. Merck& Co Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 103. Merck& Co Recent Development
Table 104. Teijin Pharma Company Details
Table 105. Teijin Pharma Business Overview
Table 106. Teijin Pharma Product
Table 107. Teijin Pharma Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 108. Teijin Pharma Recent Development
Table 109. Regeneron Pharmaceuticals Business Overview
Table 110. Regeneron Pharmaceuticals Product
Table 111. Regeneron Pharmaceuticals Company Details
Table 112. Regeneron Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 113. Regeneron Pharmaceuticals Recent Development
Table 114. Polaris Company Details
Table 115. Polaris Business Overview
Table 116. Polaris Product
Table 117. Polaris Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 118. Polaris Recent Development
Table 119. BioCryst Pharmaceuticals Company Details
Table 120. BioCryst Pharmaceuticals Business Overview
Table 121. BioCryst Pharmaceuticals Product
Table 122. BioCryst Pharmaceuticals Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 123. BioCryst Pharmaceuticals Recent Development
Table 124. Nippon Chemiphar Company Details
Table 125. Nippon Chemiphar Business Overview
Table 126. Nippon Chemiphar Product
Table 127. Nippon Chemiphar Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 128. Nippon Chemiphar Recent Development
Table 129. JW Pharmaceutical Company Details
Table 130. JW Pharmaceutical Business Overview
Table 131. JW Pharmaceutical Product
Table 132. JW Pharmaceutical Revenue in Gout Disease Treatment Business (2015-2020) (Million US$)
Table 133. JW Pharmaceutical Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gout Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acute Gout Features
Figure 3. Chronic Gout Features
Figure 4. Global Gout Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Homecare Settings Case Studies
Figure 8. Others Case Studies
Figure 9. Gout Disease Treatment Report Years Considered
Figure 10. Global Gout Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gout Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Gout Disease Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gout Disease Treatment Market Share by Players in 2019
Figure 15. Global Top Gout Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Disease Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gout Disease Treatment Revenue in 2019
Figure 17. North America Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gout Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
痛風治療薬の世界市場（～2026年） Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries. Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to …- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
- ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
- 慢性閉塞性肺疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Obstructive…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…